13D·WATCH Activist + Insider Intelligence Live feed Blog About Pricing
SCHEDULE 13D/A Filed 2026-08-13 Event 2026-08-12 SEC 0001104659-26-096202 →

Griffiths Richard Ian Silence Therapeutics Plc SLNCF

Stake: Shares: 14,391,498 Class: Ordinary Shares, nominal value of PS0.05 per share

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)
0 transactions
0 buys · 0 sales · 0 awards/exercises
Issuer Cluster
4 13D/G filings on this issuer
3 other filings besides this one
Filer Track Record
4 filings by this filer
3 other filings in the data moat
Short Interest · settle 2026-06-15
DTC 1.00
39 shares short · 0.0% vs prior

Institutional Consensus · 2025-12-31

Held by elite portfolio managers
1 holder · $694K
Point72 Asset Mgmt

Other 13D/G Filings on Silence Therapeutics Plc

FiledFormFilerStakeShares
2026-07-08 SCHEDULE 13D/A Griffiths Richard Ian 21.70% 30,844,458 view →
2023-08-14 SC Griffiths Richard Ian view →
2022-07-20 SC Griffiths Richard Ian view →

Other Filings by Griffiths Richard Ian

FiledFormIssuerStakeShares
2026-07-08 SCHEDULE 13D/A Silence Therapeutics Plc SLNCF 21.70% 30,844,458 view →
2023-08-14 SC Silence Therapeutics plc SLNCF view →
2022-07-20 SC Silence Therapeutics plc SLNCF view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →